RMRoxana Moayedifar

Roxana Moayedifar

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Roxana Moayedifar has a total of 103 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Donor-Recipient Sex Mismatch is Associated with Severe Primary Graft Dysfunction after Heart Transplantation

    by Roxana Moayedifar, Andreas Zuckerman, Yasbanoo Moayedi, Rong Huang, Nititsh K. Dhingra, Lauren K. Truby, Jiho Han, Erik Henricksen, Eduard Ródenas-Alesina, Joan Guzman-Bofarull, et al.

  • Short-Term Mechanical Circulatory Support Before Heart Transplantation and Early Outcomes: Insights From the International Primary Graft Dysfunction Consortium

    by Mercedes Rivas-Lasarte, Eduard Rodenas-Alesina, Yasbanoo Moayedi, Lauren K. Truby, Farid Foroutan, Erik Henricksen, Marisa Signorile, Nitish K. Dhingra, Laura Hastenteufel, Chun-Po S. Fan, et al.

  • Open Access

    Efficacy of Antimicrobial Silver‐Plated Dressings Compared to Usual Care in Preventing Left Ventricular Assist Device Driveline Infections

    by Barbara Veiter, Martina Socha, Christiane Marko, Nesibe Seyda Colak, Alexandra Kuhn, Hebe Al Asadi, Julia Riebandt, Roxana Moayedifar, Daniel Zimpfer, Thomas Schlöglhofer

    Background: Left ventricular assist device (LVAD) driveline infections (DLIs) represent one of the most common adverse events in LVAD patients. This study investigates the effectiveness of a silver‐plated antimicrobial dressing (Silverlon, Bravida Medical) in addition to usual driveline wound care for DLI‐prevention. The primary outcome was six‐months freedom from DLI. Secondary outcomes included independent risk factors for DLI, freedom from DLI‐related hospital readmission, freedom from negative pressure wound therapy (NPWT) and temporal changes in DESTINE wound staging. Methods: This single center cohort study included 61 patients implanted with a HeartMate 3 LVAD between 2022 and 2025 (8.2% female; median age 61 (55; 67 IQR) years; BMI 27.2 (±4.42 STD) kg/m 2 ). Starting with the first follow‐up visit (FFUV) after hospital discharge, 39 patients received usual wound care, while 22 patients additionally received Silverlon. Results: The Silverlon group demonstrated a significantly greater freedom from DLI (100% vs. 71.8%; p = 0.017). No independent predictors of DLI were identified due to the complete absence of DLIs in the Silverlon group (0 vs. 11 events); multivariable Cox regression effect could not be mathematically estimated. The Silverlon group showed 100% freedom from DLI‐related readmission and NPWT therapy (vs. 97.4%; p = 0.45). DESTINE stages 0–1 predominated within the Silverlon group; severe stages (3, 4) occurred exclusively within the usual care group ( p > 0.22). Conclusion: Given the substantial burden of DLI, integrating silver‐plated wound dressings into standard LVAD wound care appears to be a safe and effective strategy, associated with enhanced wound healing and a reduction in DLI incidence.

  • Open Access

    Association of Hemodynamic Parameters with Clinical Outcomes in Cardiogenic Shock: Insights from Full-Flow Micro-Axial Flow Pump Data in a Retrospective Single-Center Study

    by Julia Riebandt, Roxana Moayedifar, Lukas Ruoff, Hebe Al Asadi, Sanja Söllner, Rabab Saleh, Oliver Seibert, Barbara Karner, Anne-Kristin Schaefer, Daniel Zimpfer, et al.

    Objectives: The Impella 5.5 (J&J MedTech, USA) is increasingly used for refractory cardiogenic shock (CS), yet early predictors of mortality and recovery remain unclear. This study aimed to evaluate early patient characteristics and device-related parameters in relation to clinical outcomes; to compare outcome-based phenotypic groups (native heart recovery (NHR), heart replacement therapy (HRT), and death on the device (DEC)); and to analyze P-level impact on hemolysis and acute kidney injury. Methods: This retrospective single-center study included 28 CS patients supported with Impella 5.5 between May 2023 and August 2024. Data included intensive care unit (ICU) hemodynamics, vasoactive-inotropic score (VIS), lab markers, and pump parameters. Primary analysis evaluated early (first 24 h) parameters as potential indicators associated with mortality on the device and recovery, while secondary analyses compared hemodynamic and pump performance parameters across outcome groups, evaluated the association between P-level and hemolysis, and assessed the impact of shock etiology on clinical outcomes. Results: Among 28 patients (mean age 56 years, 10.7% female, body mass index (BMI) 27.7 kg/m2), NHR occurred in 39.3% and bridged to HRT in 42.9%. Non-survivors (17.8%) had significantly higher lactate (3.1 vs. NHR: 1.9 vs. HRT: 1.4 mmol/L, p < 0.001) and VIS (307.0 vs. NHR: 18.8 vs. HRT: 12.6, p < 0.001) at implantation. Higher VIS values (>69) were strongly associated with mortality on the device, with 100% sensitivity and 77% specificity (area under the curve (AUC) = 0.86); VIS < 9.9 was related to NHR (AUC = 0.63, 94% sensitivity, 45% specificity). P-levels were not linked to hemolysis index (r = −0.03, p = 0.64) or lactate dehydrogenase (r = −0.06, p = 0.37). Conclusions: Early vasoactive burden was associated with clinical outcomes in Impella 5.5-supported patients. No association between P-levels and the analyzed hemolysis surrogates was detected in this cohort. Distinct phenotypes across recovery outcomes may guide personalized management, but prospective validation of this exploratory and hypothesis-generating analysis is needed.

  • Open Access

    Non-invasive analysis of pump parameter responses to orthostatic transitions in patients with fully magnetically levitated left ventricular assist devices

    by Lukas Ruoff, Gregor Widhalm, Michael Röhrich, Hebe Al Asadi, Luca Conci, Christiane Marko, Roxana Moayedifar, Daniel Zimpfer, Julia Riebandt, Thomas Schlöglhofer

    Aims: Despite the excellent clinical outcomes of the HeartMate 3 (HM3) left ventricular assist device, the current pump monitoring limits in-depth pump data analysis. This study investigated HM3 pump parameters collected non-invasively with HM3 Snoopy during orthostatic transitions (OTs). Methods and results: In this single-centre cohort study, a standardized OT protocol was developed, involving postural changes between supine, seated, and standing. Data were recorded using the HM3 Snoopy and a Holter electrocardiogram. Pump flows (QMIN, QMEAN, QMAX), pulsatility index (PI), pump speed, MagLev parameters, and heart rate were synchronized per second. The primary outcome was the identification of distinct orthostatic pump flow response phenotypes. Further, a binary classifier using MagLev parameters, to differentiate between supine and upright patient positions, was developed and assessed. In 25 HM3 patients (age: 61.2 ± 9.6 years, female: 12%, body mass index: 26.8 ± 4.7 kg/m2), greater flow alterations were observed during transitions from supine to standing vs. seated to standing, with most significant changes in QMIN [3 (-13; 10)%]. Phenotypes were identified across 75 OTs as no flow response (60%), undesired unloading with a loss in QMIN ≥ 50% (20%), and loss of pulsatility ≥ 50% (16%). The MagLev patient position classifier achieved a median sensitivity of 88% and specificity of 86% across the entire cohort. Conclusion: Three HM3 pump flow response phenotypes were identified in response to OTs, challenging the utilization of PI events to detect undesired unloading events. A MagLev-based position classifier revealed potential for differentiation of HM3 patient position.

  • Open Access

    Prognostic Significance of Albumin in Modern Left Ventricular Assist Device Therapy: Relevance in the HeartMate 3 Era?

    by Roxana Moayedifar, Muhammed Celik, Barbara Karner, Anne-Kristin Schaefer, Hebe Al Asadi, Christiane Marko, Lukas Ruoff, Daniel Zimpfer, Julia Riebandt, Thomas Schlöglhofer

    Background/Objectives: Preoperative hypoalbuminemia is a known risk factor for adverse outcomes in cardiac surgery, but its role in patients undergoing HeartMate 3 (HM3) left ventricular assist device (LVAD) implantation is unclear. This study evaluated the association between albumin levels and postoperative outcomes, aiming to define a clinically meaningful cut-off for risk stratification. Methods: We retrospectively analyzed 205 adult patients who underwent HM3 implantation at a single center from June 2014 to December 2023. Receiver operating characteristic (ROC) analysis identified an optimal pre-implant albumin cut-off of p = 0.004) and bleeding (38.1% vs. 23.2%, p = 0.012). Freedom from HRAEs was significantly lower in the hypoalbuminemia group (45.2% vs. 69.8%, p < 0.001) and competing risk-adjusted cumulative incidence for HRAE was higher, but did not reach statistical significance (p = 0.11), one-year HRAE-free survival was also reduced (68.5% vs. 85.7%, p = 0.03). In multivariable analysis, low albumin (HR 0.56, 95% CI 0.33–0.93, p = 0.026) and temporary right ventricular assist device (RVAD) support (HR 3.32, 95% CI 2.05–5.39, p < 0.001) were independent predictors of HRAEs. Conclusions: Low preoperative albumin is independently associated with increased HRAEs and reduced one-year survival after HM3 implantation. Compared with the traditional 35 g/L threshold, the ROC-derived 32 g/L cut-off offered superior balance between sensitivity and specificity, underscoring its clinical utility. Albumin may serve as a simple, pragmatic, and cost-effective biomarker for preoperative risk assessment and optimization.


  • Open Access

    Enhancing Left Ventricular Assist Device Usability: A Comparative Simulation Study of CorWave and HeartMate 3 Peripherals

    by Gregor Widhalm, Theodor Abart, Katharina Ebenberger, Angelika Berger, Roxana Moayedifar, Daniel Zimpfer, Julia Riebandt, Michael Wagner, Thomas Schlöglhofer

    Left ventricular assist devices (LVADs) improve outcomes but often compromise quality of life (QoL) due to usability issues with wearables. This study compared the usability of CorWave LVAD (CW) peripherals prototypes to HeartMate 3 LVAD (HM3) peripherals through a cross-sectional, simulation-based approach involving LVAD-naive laypeople, and heart transplantation (HTX) patients post-LVAD support. Simulations encompassed six tasks, measuring initial success rates, duration to success, pump-off time, and a post-scenario survey. Forty-six untrained participants (16 CW vs. 30 HM3; 12.5% vs. 20% female, p = 0.69; 56.2% vs. 50.0% HTX patients, p = 0.76) completed 276 scenarios. The CW cohort demonstrated superior initial success rates (92.7% vs. 80.6%, p = 0.008). Battery exchanges (in normal and dim light, within carry bag) were completed twice as quickly for CW users ( p ≤ 0.001). Although controller exchange success rates were comparable, the duration to success and pump-off times were doubled for the HM3 cohort ( p ≤ 0.005). During the “connection to AC power” scenario, HM3 subjects experienced higher complexity, as the CW cohort achieved 5× lower duration to success and 3× higher initial success rates ( p ≤ 0.001). Survey responses favored CW cable lengths (92.9% vs. 69.0%, p = 0.001). This study highlights the advantages of CW’s user-centered design, which may enhance QoL and safety for future LVAD patients.


  • Open Access

    Staying in Place: In Vitro Comparison of Extracorporeal Membrane Oxygenation Cannula Fixation for Dislodgment Prevention

    by Roxana Moayedifar, Johanna Schachl, Markus Königshofer, Martin Stoiber, Julia Riebandt, Daniel Zimpfer, Thomas Schlöglhofer

    Background/Objectives: Secure large-bore cannula insertion is critical for effective extracorporeal membrane oxygenation (ECMO), as inadequate fixation can lead to complications such as infection, dislodgment, and life-threatening events. With inconsistent guidelines for ECMO line management, this study compares the effectiveness of traditional suture fixation to an adhesive securement method in the prevention of ECMO cannula dislodgment using an in vitro model. Methods: Porcine skin and muscle tissue sections were prepared and mounted in a custom holder. A 21F venous ECMO cannula was inserted using a modified Seldinger technique. Three fixation methods were randomly compared: (1) three silk sutures, and (2a) one silk suture with a CathGrip adhesive anchoring device. In addition, a sub-analysis was performed using (2b) the Hollister adhesive anchoring device. A uniaxial testing machine simulated 50 mm cannula dislodgment, measuring tensile forces at 12.5, 25, and 50 mm dislodgment points. Results: A total of 26 ECMO cannula fixations using sutures, 26 with adhesive CathGrip, six with a Hollister device, and three controls were tested across six porcine samples. Sutures demonstrated greater variability in force at maximum dislocation, with 27% rupturing at 50 mm. In contrast, CathGrip provided greater flexibility without tearing. The adhesive exhibited higher stiffness (2.38 N/mm vs. 2.09 N/mm, p < 0.001) and dislodgment energy (0.034 J vs. 0.032 J, p = 0.002) in the 0–5 mm range, while sutures showed greater stiffness in the 5–50 mm range (1.42 N/mm vs. 1.18 N/mm, p < 0.001). At larger displacements (25 mm and 50 mm) and in total energy absorption, no statistically significant differences were observed (p = 0.57). In a sub-analysis, the six fixations using the Hollister device exhibited higher variability and significantly lower dislodgment forces at 25 mm (p = 0.033) and 50 mm (p = 0.004) compared to the CathGrip device. Conclusions: This study suggests that adhesive anchoring methods, such as CathGrip, may provide comparable or potentially superior fixation strength to sutures for ECMO cannula stabilization under controlled conditions. However, further research, including clinical trials, is necessary to confirm these findings, evaluate long-term performance, and explore the implications for dislodgment risk and infection prevention in clinical practice.